Cancer – AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)
Condition or Therapy:
Cancer and Blood Disorders
Study Number: AALL00932
What is the goal of this study?
Researchers want to determine how to improve disease free survival in patients with standard risk B-Acute Lymphoblastic Leukemia (ALL).
Who can join the study?
This study may be a good fit for children and young adults who:
- Are 1 to 30 years old, and
- Are newly diagnosed with standard risk B-Acute Lymphoblastic Leukemia (ALL).
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.